SyBridge Breaks into Europe with Galway Deal

The acquisition will place SyBridge in the Irish epicenter of more than 300 medical technology manufacturers.

Katie Hobbins, Managing Editor

October 11, 2022

1 Min Read
manda1 (1).jpg
Image courtesy of pichetw / Alamy Stock Photo

SyBridge Technologies, a global industrial technology company, recently announced the acquisition of Galway Tool & Mould Limited, a company based in Galway, Ireland, and leader in the precision tooling market. The transaction represents SyBridge’s first investment in Europe and its thirteenth acquisition since the company’s inception in 2019.

"Galway is an excellent addition to SyBridge's growing industrial technology platform,” said Byron J. Paul, CEO of SyBridge. “They have a long and proven track record of exceeding customer expectations in applications that require high levels of precision and quality. This transaction also marks an important milestone for SyBridge by expanding our footprint into Europe.  The addition of Galway to our Life Sciences business allows us to better serve our global customers through our operations in North America and now Europe."

Galway has been designing and manufacturing high precision, high performance molds for more than 30 years, primarily for the pharmaceutical and medical device industries. Its Galway location, according to the press release announcing the acquisition, places the company at the epicenter of Ireland’s more than 300 medical technology manufacturers. The company provides end-to-end solutions, including design and engineering to aftermarket parts, spares, and repairs.

SyBridge was created by New York-based private equity firm Crestview Partners in 2019. The firm, according to the release, committed $200 million in equity capital to create a provider offering value-added manufacturing solutions spanning end-markets, geographies, and advanced technological capabilities.

"We are very pleased to be part of SyBridge Technologies,” said Padraig McFadden, founder and managing director of Galway. “The combination of Galway's expertise in the field and SyBridge's breadth of manufacturing and technology capabilities across North America enhances opportunities for our customers and employees alike."

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like